Wealthfront Advisers’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $592K | Sell |
2,707
-864
| -24% | -$189K | ﹤0.01% | 769 |
|
|
2025
Q1 | $799K | Sell |
3,571
-1,109
| -24% | -$248K | ﹤0.01% | 703 |
|
|
2024
Q4 | $1.53M | Buy |
4,680
+1,065
| +29% | +$349K | ﹤0.01% | 582 |
|
|
2024
Q3 | $1.09M | Sell |
3,615
-659
| -15% | -$198K | ﹤0.01% | 629 |
|
|
2024
Q2 | $1.41M | Sell |
4,274
-2,345
| -35% | -$772K | ﹤0.01% | 560 |
|
|
2024
Q1 | $2.62M | Sell |
6,619
-1,701
| -20% | -$673K | 0.01% | 416 |
|
|
2023
Q4 | $2.93M | Buy |
8,320
+3,520
| +73% | +$1.24M | 0.01% | 369 |
|
|
2023
Q3 | $1.8M | Buy |
4,800
+59
| +1% | +$22.1K | 0.01% | 443 |
|
|
2023
Q2 | $1.81M | Sell |
4,741
-25
| -0.5% | -$9.56K | 0.01% | 439 |
|
|
2023
Q1 | $1.65M | Buy |
4,766
+593
| +14% | +$205K | 0.01% | 446 |
|
|
2022
Q4 | $982K | Buy |
4,173
+800
| +24% | +$188K | ﹤0.01% | 513 |
|
|
2022
Q3 | $830K | Sell |
3,373
-2,655
| -44% | -$653K | ﹤0.01% | 509 |
|
|
2022
Q2 | $1.82M | Sell |
6,028
-752
| -11% | -$227K | 0.01% | 401 |
|
|
2022
Q1 | $2.79M | Buy |
6,780
+1,011
| +18% | +$415K | 0.01% | 324 |
|
|
2021
Q4 | $2.71M | Sell |
5,769
-197
| -3% | -$92.4K | 0.01% | 326 |
|
|
2021
Q3 | $2.53M | Buy |
5,966
+77
| +1% | +$32.7K | 0.01% | 293 |
|
|
2021
Q2 | $2.12M | Sell |
5,889
-366
| -6% | -$131K | 0.01% | 292 |
|
|
2021
Q1 | $1.76M | Buy |
6,255
+1,296
| +26% | +$365K | 0.01% | 298 |
|
|
2020
Q4 | $1.41M | Buy |
4,959
+934
| +23% | +$265K | 0.01% | 301 |
|
|
2020
Q3 | $1.11M | Buy |
4,025
+682
| +20% | +$187K | 0.01% | 305 |
|
|
2020
Q2 | $759K | Buy |
+3,343
| New | +$759K | 0.01% | 364 |
|